Matches in Wikidata for { <http://www.wikidata.org/entity/Q86241788> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- Q86241788 description "artículu científicu espublizáu en setiembre de 2015" @default.
- Q86241788 description "im September 2015 veröffentlichter wissenschaftlicher Artikel" @default.
- Q86241788 description "scientific article published on 24 September 2015" @default.
- Q86241788 description "wetenschappelijk artikel" @default.
- Q86241788 description "наукова стаття, опублікована у вересні 2015" @default.
- Q86241788 name "Decitabine versus best supportive care in older patients with refractory anemia with excess blasts in transformation (RAEBt) - results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German" @default.
- Q86241788 name "Decitabine versus best supportive care in older patients with refractory anemia with excess blasts in transformation (RAEBt) - results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German" @default.
- Q86241788 type Item @default.
- Q86241788 label "Decitabine versus best supportive care in older patients with refractory anemia with excess blasts in transformation (RAEBt) - results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German" @default.
- Q86241788 label "Decitabine versus best supportive care in older patients with refractory anemia with excess blasts in transformation (RAEBt) - results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German" @default.
- Q86241788 prefLabel "Decitabine versus best supportive care in older patients with refractory anemia with excess blasts in transformation (RAEBt) - results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German" @default.
- Q86241788 prefLabel "Decitabine versus best supportive care in older patients with refractory anemia with excess blasts in transformation (RAEBt) - results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German" @default.
- Q86241788 P1433 Q86241788-B39B9899-5097-42F2-9C41-08B9B1295688 @default.
- Q86241788 P1476 Q86241788-0C710B48-EA81-47A1-91E8-5A4795139E61 @default.
- Q86241788 P2093 Q86241788-0221AC12-F858-49B7-8059-7380D50D5349 @default.
- Q86241788 P2093 Q86241788-0EA78C88-F078-4AD3-AC9F-F8A80405FC68 @default.
- Q86241788 P2093 Q86241788-3C225C7E-E23E-4A46-BF65-387F133435D6 @default.
- Q86241788 P2093 Q86241788-4CFA38AE-37A8-4114-8038-8CEE8709629B @default.
- Q86241788 P2093 Q86241788-782AF1FC-0A28-4D9C-9D00-D04450F10351 @default.
- Q86241788 P2093 Q86241788-823D9FD7-0E63-4953-AAB3-05AA1C825CE4 @default.
- Q86241788 P2093 Q86241788-8637CCE0-CEFA-4CE8-90EE-28729937510A @default.
- Q86241788 P2093 Q86241788-8CCFB1C3-49F9-4B84-9934-DFDC0BF08724 @default.
- Q86241788 P2093 Q86241788-92FED162-2220-491B-A78F-06D068F75B2E @default.
- Q86241788 P2093 Q86241788-99CD86AD-78E0-4532-AF00-211C90BD33A2 @default.
- Q86241788 P2093 Q86241788-9EAD2B2D-F503-4259-8106-C39FF1173F8C @default.
- Q86241788 P2093 Q86241788-B1163324-8729-44D7-A506-1DAE8207ACD1 @default.
- Q86241788 P2093 Q86241788-CC356DC7-81E0-446A-9D54-4751B61AA141 @default.
- Q86241788 P2093 Q86241788-DD65BB95-957A-47FE-9564-872186ED9827 @default.
- Q86241788 P2093 Q86241788-E4330BC1-1F2A-4023-9D74-14C4E3BB64C6 @default.
- Q86241788 P2093 Q86241788-F888A417-51C5-4E44-8768-77F88F855D0C @default.
- Q86241788 P2093 Q86241788-FCD5E4BF-878B-4DF2-91A1-C723F5041E16 @default.
- Q86241788 P304 Q86241788-BD322E2B-3BC2-4F50-9933-2553F89FFE56 @default.
- Q86241788 P31 Q86241788-1982F417-3594-4611-8D0D-F8CB2187B96A @default.
- Q86241788 P356 Q86241788-A2274BE3-4559-4831-AEDB-13DEF6DD54A9 @default.
- Q86241788 P433 Q86241788-8E11B634-669E-45DD-A276-B1892E931163 @default.
- Q86241788 P478 Q86241788-E04AF899-8002-44B2-B85B-CA0E841779F1 @default.
- Q86241788 P50 Q86241788-A8D7B9B9-F9ED-4F1C-A2C1-82E1EF92E1A7 @default.
- Q86241788 P50 Q86241788-DFA34694-4D1B-4D33-A3C4-56034F90BFD5 @default.
- Q86241788 P50 Q86241788-EAC9123C-CE6D-493F-B54F-B80F4D436B63 @default.
- Q86241788 P577 Q86241788-DD13AE5F-50E4-4888-9E4D-40BAB84FB911 @default.
- Q86241788 P698 Q86241788-676762EC-7C2C-495E-88C4-58394B28FA17 @default.
- Q86241788 P921 Q86241788-9F8AC805-8EC1-40FE-80F4-BF03A404D7EC @default.
- Q86241788 P356 S00277-015-2489-6 @default.
- Q86241788 P698 26400023 @default.
- Q86241788 P1433 Q15766509 @default.
- Q86241788 P1476 "Decitabine versus best supportive care in older patients with refractory anemia with excess blasts in transformation (RAEBt) - results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study Group (GMDSSG)" @default.
- Q86241788 P2093 "Anne Hagemeijer" @default.
- Q86241788 P2093 "Aristoteles Giagounidis" @default.
- Q86241788 P2093 "Arnold Ganser" @default.
- Q86241788 P2093 "Björn Hans Rüter" @default.
- Q86241788 P2093 "Boris Labar" @default.
- Q86241788 P2093 "Carlo Aul" @default.
- Q86241788 P2093 "Dominik Selleslag" @default.
- Q86241788 P2093 "Frédéric Baron" @default.
- Q86241788 P2093 "Hans-Eckart Schaefer" @default.
- Q86241788 P2093 "Heiko Becker" @default.
- Q86241788 P2093 "Helmut R Salih" @default.
- Q86241788 P2093 "Karl-Heinz Pflüger" @default.
- Q86241788 P2093 "Michael Lübbert" @default.
- Q86241788 P2093 "Pierre W Wijermans" @default.
- Q86241788 P2093 "Theo de Witte" @default.
- Q86241788 P2093 "Ulrich Germing" @default.
- Q86241788 P2093 "Valeria Fiaccadori" @default.
- Q86241788 P304 "2003-2013" @default.
- Q86241788 P31 Q13442814 @default.
- Q86241788 P356 "10.1007/S00277-015-2489-6" @default.
- Q86241788 P433 "12" @default.
- Q86241788 P478 "94" @default.
- Q86241788 P50 Q71792160 @default.
- Q86241788 P50 Q87993081 @default.
- Q86241788 P50 Q99568574 @default.
- Q86241788 P577 "2015-09-24T00:00:00Z" @default.
- Q86241788 P698 "26400023" @default.
- Q86241788 P921 Q55785650 @default.